Maree T. Smith AC

Emeritus Professor, Director, CIPDD, School of Biomedical Sciences, The University of Queensland.

[CIPDD SBMS @cipdd_sbms]

J-2156 .... alleviated hindpaw hypersensitivity in the streptozotocin-induced rat model of painful diabetic neuropathy but with a 2-fold decrease in potency at an advanced stage in the model, mimicking morphine

https://t.co/P9woZarT1W

@MareeSmith19

[Queensland Brain Institute, UQ @QldBrainInst]

What a great way to kick-off Day 2 at the @AusNeuroSoc Meeting! Professor Elizabeth Coulson discussing her research into ageing and dementia at the Lawrie Austin Plenary Lecture. #UQ #QBI #brain #ANS2023

[CIPDD SBMS @cipdd_sbms]

Angiotensin II type 2 receptor signalling as a pain target: Bench, bedside and back-translation

Andrew J. Shepherd, Andrew SC. Rice, Maree T. Smith

https://t.co/YLQ5h97Ivm @MareeSmith19

[ScienceGovAu @ScienceGovAu]

‘To get a drug from the lab…through clinical trials and into patients in under 10 years is a great achievement.’

Learn about A Prof Lara Herrero (@lara_marcus @Griffith_Uni @GlycoGriffith), 2023 Prize for New Innovators recipient: https://t.co/99yTpNw9Vl

#PMPrizes

[Translational Research Institute Australia @TRI_info]

Flashback Friday: congratulations, Professor @chamindie Punyadeera, our TRI affiliate now a @ATSE_au Fellow for 2023. Keep innovating and progressing biomedical research through development of saliva-based diagnostics! Read more at https://t.co/QuAOuLD34m

[Governor of Queensland @QldGovernor]

Professor Nimmo attended the launch of 'Doctors for the World', a book by University of Queensland Emeritus Professor John Pearn AO RFD that documents the history of the Mayne Medical School and acknowledges the impact of some 18,000 doctors who have graduated since 1936 @UQ_News

[Dr Marguerite Evans-Galea AM @MVEG001]

Today, I’m delighted to share I formally begin my exciting new role as Director of the Cell and Gene Catalyst, a joint venture of two peak industry bodies - @AusBiotech and @MedicinesAus I am proud to lead this initiative in collaboration with an Expert Advisory Group of industry leaders from @CellTherapies_ @Novartis @Pfizer @TIA_Aust and @CSL. <cont…>

The Catalyst will engage and collaborate with the sector to ensure everyone in Australia has ready access to world-class treatments such as cancer immunotherapies, cell and gene therapies and gene-editing therapeutics. As an industry-led initiative, the Catalyst will strengthen the cell and gene therapy ecosystem nationally, with an emphasis on growing our capabilities across the entire value chain.

The Catalyst will focus on accelerating the development, translation, commercialisation and manufacturing of cell and gene therapies in Australia. This will position us as a leader on the international stage, boosting our health and economy. Through industry-led education and training, the Catalyst will also enable the creation of new jobs in this rapidly expanding industry for Australia’s diverse, skilled #STEM workforce.

As Director, I am excited to apply my experience and expertise in cell and gene therapies, public policy and advocacy, and STEM workforce capacity-building. I aim to facilitate connections, opportunities and growth of Australia’s dynamic and vibrant advanced therapeutics sector.

On a personal note, it is immensely rewarding for me to return to the health sector and enhance the field to which I devoted more than 15 years of my research career. This fits with my ‘why’.

As a sector we all work together to help people living debilitating disease.

I am delighted to join the dynamic AusBiotech team at our beautiful office on Collins Street in the heart of Melbourne’s CBD. Be sure to stop by and hear our latest. The coffee is great, the people are even better! ☕️🤩

[Laura Fenlon PhD @LauraRoseFenlon]

New work from our lab out now in @NatureComms! A similarly sized marsupial takes 3x longer to develop than a mouse, but do all cortical neurodevelopmental processes temporally scale to different timeframe uniformly? No! 🦘👩‍🔬🧠🔬https://t.co/mo1uc5fnQm

[Australian Pain Soc @AusPainSoc]

Submit Your Topical Workshop Proposals for the @IASPpain 2024 World Congress on Pain: https://t.co/KnVt1Nnngy
Deadline: 11OCT23

[Julia Pagan Lab @LabPagan]

First PhD completed in our lab!! We are so proud of you Dr @DienGiang , your hard work has paid off! 👩🏻‍🎓🥳

[TIA @TIA_Aust]

Pipeline Accelerator 2022-23 (Round 2) outcomes - https://t.co/bm1Z7KzRiW

[CIPDD SBMS @cipdd_sbms]

In Vitro Assessment of the Metabolic Stability of Two Novel Endomorphin-2 Analogs, CYX-5 and CYX-6, in Rat Liver Microsomes

https://t.co/cBwKC27vSg @MareeSmith19

[CIPDD SBMS @cipdd_sbms]

The NLRP3 inflammasome: role in the pathobiology of chronic pain

https://t.co/HElFPNX0sJ @MareeSmith19

[UON Nutrition @UONnutrition]

Excited &amp; so proud of our always inspiring leader @ProfCCollins on yet another big achievement, awarded Officer of the Order of Australia today, recognised for her great contributions to nutrition &amp; health. @Uni_Newcastle @HMRIAustralia 🎉🎖️👏😄

[Laureate Prof Clare Collins AO @ProfCCollins]

Very honoured to be awarded Officer of the Order of Australia today at NSW Government House by her Excellency Governor Margaret Beazley AC KC ⁦@Uni_Newcastle⁩ ⁦@HMRIAustralia⁩

[Saleha Akter @salehaakter10]

New publication from the group:
https://t.co/29EQDAVHJe
Well done team!

[IASP @IASPpain]

Happy 50th Anniversary, IASP. From our humble beginnings at Providence Heights Conference Center to our current global network of experts, we're proud to have advanced the study and treatment of pain. Join us in celebrating #IASP50. https://t.co/QiFJHbIHMh

[Journal of Experimental Medicine @JExpMed]

We recently got the opportunity to speak with Kate Schroder @inflammasomelab @IMBatUQ about gender equality in STEM. In honor of #IWD2023, check out her interview and steps her institute is taking to support #WomeninSTEM: https://t.co/xqETtO7tdN

[CIPDD SBMS @cipdd_sbms]

Multitargeted Opioid Ligand Discovery as a Strategy to Retain Analgesia and Reduce Opioid-Related Adverse Effects https://t.co/3J7feMYxYF @MareeSmith19

[Amy Smith @amy_smith90]

Excited to share a recent case series we wrote on two interesting patients with thymic carcinoma https://t.co/WE0qKdXXsJ #thymiccarcinoma #sjogrenssyndrome #casereportsinoncology